Effects of Zofenopril on Arterial Stiffness in Hypertension Patients

Angiotensin-converting enzyme inhibitors (ACEIs) reduce arterial stiffness beyond their antihypertensive effect. Studies showed that sulfhydryl ACEIs have the antioxidative potential to improve endothelial function, which might have a clinical effect on arterial distensibility. However, there are no...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biotechnology 2023-09
Main Authors: Palić, Benjamin, Brizić, Ivica, Sher, Emina Karahmet, Cvetković, Ivona, Džidić-Krivić, Amina, Abdelghani, Heba Taha Mohmmed, Sher, Farooq
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c324t-e6f1ca1ff1428af87c8a2e2d0faa4da93b274628ad2af977dd495c1b60c52fff3
cites cdi_FETCH-LOGICAL-c324t-e6f1ca1ff1428af87c8a2e2d0faa4da93b274628ad2af977dd495c1b60c52fff3
container_end_page
container_issue
container_start_page
container_title Molecular biotechnology
container_volume
creator Palić, Benjamin
Brizić, Ivica
Sher, Emina Karahmet
Cvetković, Ivona
Džidić-Krivić, Amina
Abdelghani, Heba Taha Mohmmed
Sher, Farooq
description Angiotensin-converting enzyme inhibitors (ACEIs) reduce arterial stiffness beyond their antihypertensive effect. Studies showed that sulfhydryl ACEIs have the antioxidative potential to improve endothelial function, which might have a clinical effect on arterial distensibility. However, there are no studies that directly compare the effects of sulfhydryl (zofenopril) and non-sulfhydryl ACEIs (enalapril) on arterial stiffness. Therefore, this prospective study aims to compare the effects of enalapril and zofenopril on arterial stiffness and oxidative stress in both short- and long-term treatment of arterial hypertension (AH). Baseline and post-treatment peripheral and central arterial pressure indices, augmentation index (Aix), aortic pulse wave velocity (ao-PWV), serum levels of oxidized low-density cholesterol lipoprotein, LDL and uric acid (UA) were measured. The results showed that acute treatment with zofenopril, in contrast to enalapril, significantly decreased peripheral and central Aix (p 
doi_str_mv 10.1007/s12033-023-00861-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2864620195</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2864620195</sourcerecordid><originalsourceid>FETCH-LOGICAL-c324t-e6f1ca1ff1428af87c8a2e2d0faa4da93b274628ad2af977dd495c1b60c52fff3</originalsourceid><addsrcrecordid>eNotkMtKQzEQhoMoWKsv4CpLN9FJcnIuy1LrBQoK6sZNSHMyEDlNapIu-vZG62KYgf-bgfkIueZwywG6u8wFSMlA1IK-5UydkBlXamAgQZ3WGTrJWujVObnI-QtAcNXIGblfITpbMo1IPyO6EHfJTzQGukjFJW8m-lY8YnA5Ux_o02HnahCyr8irKd6Fki_JGZopu6v_PicfD6v35RNbvzw-LxdrZqVoCnMtcms4Im9Eb7DvbG-EEyOgMc1oBrkRXdPWaBQGh64bx2ZQlm9asEogopyTm-PdXYrfe5eL3vps3TSZ4OI-a9G3dR_4oCoqjqhNMefkUNe_tiYdNAf9q0wflemqTP8p00r-AAVGX7M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2864620195</pqid></control><display><type>article</type><title>Effects of Zofenopril on Arterial Stiffness in Hypertension Patients</title><source>Springer Nature</source><creator>Palić, Benjamin ; Brizić, Ivica ; Sher, Emina Karahmet ; Cvetković, Ivona ; Džidić-Krivić, Amina ; Abdelghani, Heba Taha Mohmmed ; Sher, Farooq</creator><creatorcontrib>Palić, Benjamin ; Brizić, Ivica ; Sher, Emina Karahmet ; Cvetković, Ivona ; Džidić-Krivić, Amina ; Abdelghani, Heba Taha Mohmmed ; Sher, Farooq</creatorcontrib><description>Angiotensin-converting enzyme inhibitors (ACEIs) reduce arterial stiffness beyond their antihypertensive effect. Studies showed that sulfhydryl ACEIs have the antioxidative potential to improve endothelial function, which might have a clinical effect on arterial distensibility. However, there are no studies that directly compare the effects of sulfhydryl (zofenopril) and non-sulfhydryl ACEIs (enalapril) on arterial stiffness. Therefore, this prospective study aims to compare the effects of enalapril and zofenopril on arterial stiffness and oxidative stress in both short- and long-term treatment of arterial hypertension (AH). Baseline and post-treatment peripheral and central arterial pressure indices, augmentation index (Aix), aortic pulse wave velocity (ao-PWV), serum levels of oxidized low-density cholesterol lipoprotein, LDL and uric acid (UA) were measured. The results showed that acute treatment with zofenopril, in contrast to enalapril, significantly decreased peripheral and central Aix (p &lt; 0.001). Chronic treatment with zofenopril showed a superior effect over enalapril on the reduction of the peripheral systolic arterial pressure with reduction of ao-PWV (p = 0.004), as well as a reduction in peripheral Aix (p = 0.021) and central Aix (p = 0.021). Therefore, this study indicates that zofenopril has beneficial effects on the reduction of arterial stiffness compared to enalapril. It has potent clinical efficacy in AH treatment and further studies should compare its safety and long-term efficacy to other AH drugs that would aid clinicians in treating AH and other various cardiovascular diseases that have arterial stiffness as a common denominator.</description><identifier>ISSN: 1073-6085</identifier><identifier>EISSN: 1559-0305</identifier><identifier>DOI: 10.1007/s12033-023-00861-5</identifier><language>eng</language><ispartof>Molecular biotechnology, 2023-09</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c324t-e6f1ca1ff1428af87c8a2e2d0faa4da93b274628ad2af977dd495c1b60c52fff3</citedby><cites>FETCH-LOGICAL-c324t-e6f1ca1ff1428af87c8a2e2d0faa4da93b274628ad2af977dd495c1b60c52fff3</cites><orcidid>0000-0003-2890-5912</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Palić, Benjamin</creatorcontrib><creatorcontrib>Brizić, Ivica</creatorcontrib><creatorcontrib>Sher, Emina Karahmet</creatorcontrib><creatorcontrib>Cvetković, Ivona</creatorcontrib><creatorcontrib>Džidić-Krivić, Amina</creatorcontrib><creatorcontrib>Abdelghani, Heba Taha Mohmmed</creatorcontrib><creatorcontrib>Sher, Farooq</creatorcontrib><title>Effects of Zofenopril on Arterial Stiffness in Hypertension Patients</title><title>Molecular biotechnology</title><description>Angiotensin-converting enzyme inhibitors (ACEIs) reduce arterial stiffness beyond their antihypertensive effect. Studies showed that sulfhydryl ACEIs have the antioxidative potential to improve endothelial function, which might have a clinical effect on arterial distensibility. However, there are no studies that directly compare the effects of sulfhydryl (zofenopril) and non-sulfhydryl ACEIs (enalapril) on arterial stiffness. Therefore, this prospective study aims to compare the effects of enalapril and zofenopril on arterial stiffness and oxidative stress in both short- and long-term treatment of arterial hypertension (AH). Baseline and post-treatment peripheral and central arterial pressure indices, augmentation index (Aix), aortic pulse wave velocity (ao-PWV), serum levels of oxidized low-density cholesterol lipoprotein, LDL and uric acid (UA) were measured. The results showed that acute treatment with zofenopril, in contrast to enalapril, significantly decreased peripheral and central Aix (p &lt; 0.001). Chronic treatment with zofenopril showed a superior effect over enalapril on the reduction of the peripheral systolic arterial pressure with reduction of ao-PWV (p = 0.004), as well as a reduction in peripheral Aix (p = 0.021) and central Aix (p = 0.021). Therefore, this study indicates that zofenopril has beneficial effects on the reduction of arterial stiffness compared to enalapril. It has potent clinical efficacy in AH treatment and further studies should compare its safety and long-term efficacy to other AH drugs that would aid clinicians in treating AH and other various cardiovascular diseases that have arterial stiffness as a common denominator.</description><issn>1073-6085</issn><issn>1559-0305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNotkMtKQzEQhoMoWKsv4CpLN9FJcnIuy1LrBQoK6sZNSHMyEDlNapIu-vZG62KYgf-bgfkIueZwywG6u8wFSMlA1IK-5UydkBlXamAgQZ3WGTrJWujVObnI-QtAcNXIGblfITpbMo1IPyO6EHfJTzQGukjFJW8m-lY8YnA5Ux_o02HnahCyr8irKd6Fki_JGZopu6v_PicfD6v35RNbvzw-LxdrZqVoCnMtcms4Im9Eb7DvbG-EEyOgMc1oBrkRXdPWaBQGh64bx2ZQlm9asEogopyTm-PdXYrfe5eL3vps3TSZ4OI-a9G3dR_4oCoqjqhNMefkUNe_tiYdNAf9q0wflemqTP8p00r-AAVGX7M</recordid><startdate>20230913</startdate><enddate>20230913</enddate><creator>Palić, Benjamin</creator><creator>Brizić, Ivica</creator><creator>Sher, Emina Karahmet</creator><creator>Cvetković, Ivona</creator><creator>Džidić-Krivić, Amina</creator><creator>Abdelghani, Heba Taha Mohmmed</creator><creator>Sher, Farooq</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2890-5912</orcidid></search><sort><creationdate>20230913</creationdate><title>Effects of Zofenopril on Arterial Stiffness in Hypertension Patients</title><author>Palić, Benjamin ; Brizić, Ivica ; Sher, Emina Karahmet ; Cvetković, Ivona ; Džidić-Krivić, Amina ; Abdelghani, Heba Taha Mohmmed ; Sher, Farooq</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c324t-e6f1ca1ff1428af87c8a2e2d0faa4da93b274628ad2af977dd495c1b60c52fff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palić, Benjamin</creatorcontrib><creatorcontrib>Brizić, Ivica</creatorcontrib><creatorcontrib>Sher, Emina Karahmet</creatorcontrib><creatorcontrib>Cvetković, Ivona</creatorcontrib><creatorcontrib>Džidić-Krivić, Amina</creatorcontrib><creatorcontrib>Abdelghani, Heba Taha Mohmmed</creatorcontrib><creatorcontrib>Sher, Farooq</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palić, Benjamin</au><au>Brizić, Ivica</au><au>Sher, Emina Karahmet</au><au>Cvetković, Ivona</au><au>Džidić-Krivić, Amina</au><au>Abdelghani, Heba Taha Mohmmed</au><au>Sher, Farooq</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Zofenopril on Arterial Stiffness in Hypertension Patients</atitle><jtitle>Molecular biotechnology</jtitle><date>2023-09-13</date><risdate>2023</risdate><issn>1073-6085</issn><eissn>1559-0305</eissn><abstract>Angiotensin-converting enzyme inhibitors (ACEIs) reduce arterial stiffness beyond their antihypertensive effect. Studies showed that sulfhydryl ACEIs have the antioxidative potential to improve endothelial function, which might have a clinical effect on arterial distensibility. However, there are no studies that directly compare the effects of sulfhydryl (zofenopril) and non-sulfhydryl ACEIs (enalapril) on arterial stiffness. Therefore, this prospective study aims to compare the effects of enalapril and zofenopril on arterial stiffness and oxidative stress in both short- and long-term treatment of arterial hypertension (AH). Baseline and post-treatment peripheral and central arterial pressure indices, augmentation index (Aix), aortic pulse wave velocity (ao-PWV), serum levels of oxidized low-density cholesterol lipoprotein, LDL and uric acid (UA) were measured. The results showed that acute treatment with zofenopril, in contrast to enalapril, significantly decreased peripheral and central Aix (p &lt; 0.001). Chronic treatment with zofenopril showed a superior effect over enalapril on the reduction of the peripheral systolic arterial pressure with reduction of ao-PWV (p = 0.004), as well as a reduction in peripheral Aix (p = 0.021) and central Aix (p = 0.021). Therefore, this study indicates that zofenopril has beneficial effects on the reduction of arterial stiffness compared to enalapril. It has potent clinical efficacy in AH treatment and further studies should compare its safety and long-term efficacy to other AH drugs that would aid clinicians in treating AH and other various cardiovascular diseases that have arterial stiffness as a common denominator.</abstract><doi>10.1007/s12033-023-00861-5</doi><orcidid>https://orcid.org/0000-0003-2890-5912</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-6085
ispartof Molecular biotechnology, 2023-09
issn 1073-6085
1559-0305
language eng
recordid cdi_proquest_miscellaneous_2864620195
source Springer Nature
title Effects of Zofenopril on Arterial Stiffness in Hypertension Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A05%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Zofenopril%20on%20Arterial%20Stiffness%20in%20Hypertension%20Patients&rft.jtitle=Molecular%20biotechnology&rft.au=Pali%C4%87,%20Benjamin&rft.date=2023-09-13&rft.issn=1073-6085&rft.eissn=1559-0305&rft_id=info:doi/10.1007/s12033-023-00861-5&rft_dat=%3Cproquest_cross%3E2864620195%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c324t-e6f1ca1ff1428af87c8a2e2d0faa4da93b274628ad2af977dd495c1b60c52fff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2864620195&rft_id=info:pmid/&rfr_iscdi=true